DK0788480T3 - Krystallisering af levobupivacain og analoger deraf - Google Patents
Krystallisering af levobupivacain og analoger derafInfo
- Publication number
- DK0788480T3 DK0788480T3 DK95934738T DK95934738T DK0788480T3 DK 0788480 T3 DK0788480 T3 DK 0788480T3 DK 95934738 T DK95934738 T DK 95934738T DK 95934738 T DK95934738 T DK 95934738T DK 0788480 T3 DK0788480 T3 DK 0788480T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- levobupivacaine
- analogues
- crystallization
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Epoxy Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9421476A GB9421476D0 (en) | 1994-10-25 | 1994-10-25 | Process and salt |
| GBGB9504926.8A GB9504926D0 (en) | 1995-03-10 | 1995-03-10 | Crystallisation |
| PCT/GB1995/002513 WO1996012699A1 (en) | 1994-10-25 | 1995-10-23 | Crystallisation of levobupivacaine and analogues thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0788480T3 true DK0788480T3 (da) | 2003-09-29 |
Family
ID=26305863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95934738T DK0788480T3 (da) | 1994-10-25 | 1995-10-23 | Krystallisering af levobupivacain og analoger deraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5994548A (sv) |
| EP (1) | EP0788480B1 (sv) |
| JP (1) | JP3911545B2 (sv) |
| AT (1) | ATE245629T1 (sv) |
| AU (1) | AU698637B2 (sv) |
| CA (1) | CA2200355C (sv) |
| DE (1) | DE69531356T2 (sv) |
| DK (1) | DK0788480T3 (sv) |
| ES (1) | ES2202375T3 (sv) |
| FI (1) | FI117438B (sv) |
| HU (1) | HU227420B1 (sv) |
| MX (1) | MX9703024A (sv) |
| NO (1) | NO309266B1 (sv) |
| PL (1) | PL183210B1 (sv) |
| PT (1) | PT788480E (sv) |
| WO (1) | WO1996012699A1 (sv) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0002246A (pt) * | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
| BRPI0104491B8 (pt) * | 2001-10-10 | 2021-05-25 | Cristalia Produtos Quim Farmaceuticos Ltda | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| SI1575569T1 (sl) * | 2002-12-13 | 2010-12-31 | Durect Corp | Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale |
| US6790267B1 (en) * | 2003-04-24 | 2004-09-14 | Xerox Corporation | Colorant compositions |
| US7094812B2 (en) * | 2003-04-24 | 2006-08-22 | Xerox Corporations | Colorant compositions |
| BRPI0515372B8 (pt) | 2004-09-17 | 2021-05-25 | Durect Corp | composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| EP2010491A1 (en) * | 2006-04-25 | 2009-01-07 | Disham Pharmaceuticals and Chemicals Ltd. | Ropivacaine hydrochloride anhydrate and the preparation thereof |
| PL2117521T3 (pl) | 2006-11-03 | 2012-11-30 | Durect Corp | Transdermalne systemy dostarczania zawierające bupiwakainę |
| AU2008347158B8 (en) | 2007-12-06 | 2013-08-22 | Durect Corporation | Oral pharmaceutical dosage forms |
| PT2234974E (pt) * | 2008-01-15 | 2012-05-29 | Pharmathen Sa | Processo para a preparação do composto (s)-l-alquil-2',6'- pipecoloxilidida |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CN103073484B (zh) * | 2013-01-28 | 2014-10-22 | 山东诚创医药技术开发有限公司 | 一种甲哌卡因及其光学对映体的制备方法 |
| US9555113B2 (en) | 2013-03-15 | 2017-01-31 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| RU2021114918A (ru) * | 2016-12-26 | 2021-07-09 | Целликс Био Прайвет Лимитед | Композиции и способы лечения хронической боли |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE341404B (sv) * | 1967-05-18 | 1971-12-27 | Sterling Drug Inc | |
| US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
-
1995
- 1995-10-23 CA CA002200355A patent/CA2200355C/en not_active Expired - Lifetime
- 1995-10-23 AT AT95934738T patent/ATE245629T1/de active
- 1995-10-23 WO PCT/GB1995/002513 patent/WO1996012699A1/en active IP Right Grant
- 1995-10-23 HU HU9702372A patent/HU227420B1/hu unknown
- 1995-10-23 DK DK95934738T patent/DK0788480T3/da active
- 1995-10-23 PT PT95934738T patent/PT788480E/pt unknown
- 1995-10-23 MX MX9703024A patent/MX9703024A/es unknown
- 1995-10-23 ES ES95934738T patent/ES2202375T3/es not_active Expired - Lifetime
- 1995-10-23 EP EP95934738A patent/EP0788480B1/en not_active Expired - Lifetime
- 1995-10-23 PL PL95319829A patent/PL183210B1/pl unknown
- 1995-10-23 DE DE69531356T patent/DE69531356T2/de not_active Expired - Lifetime
- 1995-10-23 US US08/849,418 patent/US5994548A/en not_active Expired - Lifetime
- 1995-10-23 AU AU37048/95A patent/AU698637B2/en not_active Expired
- 1995-10-23 JP JP51373896A patent/JP3911545B2/ja not_active Expired - Lifetime
-
1997
- 1997-04-22 FI FI971711A patent/FI117438B/sv not_active IP Right Cessation
- 1997-04-24 NO NO971903A patent/NO309266B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT788480E (pt) | 2003-12-31 |
| JP3911545B2 (ja) | 2007-05-09 |
| PL319829A1 (en) | 1997-09-01 |
| HU227420B1 (en) | 2011-05-30 |
| MX9703024A (es) | 1997-10-31 |
| NO309266B1 (no) | 2001-01-08 |
| WO1996012699A1 (en) | 1996-05-02 |
| DE69531356T2 (de) | 2004-05-27 |
| NO971903D0 (no) | 1997-04-24 |
| FI971711A (sv) | 1997-04-22 |
| NO971903L (no) | 1997-04-24 |
| JPH10507464A (ja) | 1998-07-21 |
| PL183210B1 (pl) | 2002-06-28 |
| EP0788480B1 (en) | 2003-07-23 |
| HUT77631A (hu) | 1998-06-29 |
| FI117438B (sv) | 2006-10-13 |
| AU3704895A (en) | 1996-05-15 |
| FI971711A0 (sv) | 1997-04-22 |
| AU698637B2 (en) | 1998-11-05 |
| ATE245629T1 (de) | 2003-08-15 |
| CA2200355A1 (en) | 1996-05-02 |
| DE69531356D1 (de) | 2003-08-28 |
| US5994548A (en) | 1999-11-30 |
| ES2202375T3 (es) | 2004-04-01 |
| EP0788480A1 (en) | 1997-08-13 |
| CA2200355C (en) | 2007-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0788480T3 (da) | Krystallisering af levobupivacain og analoger deraf | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| DK0584136T3 (da) | Bestemmelse af peptidmotiver på MHC-molekyler | |
| DE69406522T2 (de) | Verfahren zur Herstellung von alkalilöslichen Emulsionscopolymeren | |
| DE69109401D1 (de) | Wässrige Zusammensetzungen zur Behandlung von porösen Substraten. | |
| DK0822816T3 (da) | Dermatologisk præparat til behandling af actiniske keratoser | |
| DE59103750D1 (de) | Verfahren zur teilweisen elektrolytischen Enthalogenierung von Di-und Trichloressigsäure sowie Elektrolyselösung. | |
| DE59405969D1 (de) | Verfahren zur Herstellung von Polyasparaginsäure | |
| NO20013128D0 (no) | Sementblanding og fremgangsmåte dertil | |
| DK0476113T3 (da) | Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose | |
| DE59204902D1 (de) | Verfahren zur Herstellung von Diphenylaminen | |
| DE59105224D1 (de) | Verfahren zur Herstellung von N-substituierten Pyrrolidonen. | |
| DE59407675D1 (de) | Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on | |
| DK0586589T3 (da) | Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande | |
| DK0620607T3 (da) | Fremgangsmåde til elektrolytisk behandling af brugte batterier | |
| DK0687256T3 (da) | Hydroxymethylfurazancarboxylsyrederivater og deresanvendelse ved behandling af kardiovaskulære sygdomme | |
| DE69200603T2 (de) | Verfahren zur Behandlung von verbrauchten Nickelenthaltenden Ätzlösungen. | |
| DE58902228D1 (de) | Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten. | |
| DE69103913D1 (de) | Verfahren zur Herstellung von Dodekandicarbonsäure. | |
| NO881414D0 (no) | Fremgangsmaate for behandling av spillvann og annet urent vann. | |
| DE68913394D1 (de) | Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen. | |
| ATE84780T1 (de) | Neue di(meth)acrylate, verfahren zu deren herstellung und deren verwendung. | |
| DE59106854D1 (de) | Verfahren zur Herstellung von N-(2-Chlor-pyridin-5-yl-methyl)-ethylendiamin. | |
| DK0825859T3 (da) | Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed | |
| DE69104364D1 (de) | Verfahren zur herstellung von streptograminderivaten. |